Drug therapies tailored to the DNA profiles of individual patients could change the face of medicine, but such treatments aren't commonly used in the clinic
Drug therapies tailored to the DNA profiles of individual patients could change the face of medicine, but such treatments aren't commonly used in the clinic
Is DNA damage an inevitable consequence of epigenetic reprogramming?
Postdoc forced to leave position after questioning the reproducibility of advisor's data
New compounds are showing promise in targeting subpopulations of cancer stem cells
How to follow stem cells transplanted into living tissue.
The challenges of crystallizing membrane proteins—and how they’re being overcome
A guide to the new wave of budget, easy-to-use flow cytometers